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background: We hypothesized that patients randomized to CRT-D in the MADIT-CRT trial who had significant left atrial volume (LAV) reductions 
would have a reduced risk of inappropriate ICD therapy.
methods and results: LAV change between baseline and 12-month echocardiograms was assessed in 751 CRT-D treated patients. LAV 
responders were stratified into quartiles based on percent reduction of LAV change: High LAV responders were those with the highest three quartiles 
of LAV reduction (LAV reduction >21%) and low LAV responders were those with the lowest quartile of LAV reduction (LAV reduction <21%). Clinical 
factors associated with >21% reduction in LAV with CRT therapy were evaluated by linear regression analysis and included LBBB, not having had 
prior CABG surgery, a heart rate > 80bpm on the 12-lead ECG, a lower left ventricular end systolic volume index, and a higher left ventricular ejection 
fraction. In Cox proportional-hazards regression analyses, the high LAV responders had a 39% reduction in the risk of inappropriate therapy (hazard 
ratio 0.61, p=0.04) and LBBB patients exhibited an even greater risk reduction in inappropriate therapy (hazard ratio 0.51, p=0.02). The high LAV 
responders also had a significantly lower risk of heart failure or death during long-term follow-up.
conclusions: A 21% or greater reduction in LAV with cardiac resynchronization therapy is associated with significant reductions in inappropriate 
ICD therapy and in heart failure or death during a 3-year follow-up.
